HempFusion Wellness Inc. (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has entered into a large-scale distribution agreement with Fullscript.com to launch a doctor practitioner sales channel. Fullscript is a leading eCommerce platform designed to allow health professionals to dispense professional-grade natural health products. Based on the agreement, HempFusion’s seven Biome Research SKUs will be available from Fullscript distribution centers, effective Feb. 2, 2021. The agreement is a significant step in HempFusion’s strategy to enter into the doctor practitioner sales space. Fullscript has become one of the largest distributors in the doctor practitioner sector; the platform offers nutritional supplements to more than 80,000 practitioners and more than 600,000 patients in both the United States and Canada. “We are incredibly excited to launch doctor practitioner sales starting with Biome Research, a specialized wholly owned HempFusion brand designed specifically for doctors, practitioners and their patients,” said HempFusion director of doctor/practitioner Nancy Angelini in the press release. “An industry-leading eCommerce platform like Fullscript, with a deep and established distribution network, is a tremendous advantage to HempFusion. We expect this channel to drive significant revenue growth for the company.”
To view the full press release, visit https://ibn.fm/J8cHj
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/HempFusion
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
InvestorWire is part of the InvestorBrandNetwork.